Literature DB >> 20078569

A whole of population-based series of radical prostatectomy in Victoria, 1995 to 2000.

Damien Bolton1, Gianluca Severi, Jeremy L Millar, Helen Kelsall, Adee-Jonathan Davidson, Charmaine Smith, Melisa Bagnato, John Pedersen, Graham Giles, Rodney Syme.   

Abstract

OBJECTIVE: Radical prostatectomy (RP) as a first line treatment of prostate cancer was rare prior to the advent of prostate specific antigen (PSA) testing, yet little is known of its use and outcomes in a population setting. We described baseline characteristics of cases in the Victorian Radical Prostatectomy Register (VRPR), investigated possible associations between demographic characteristics and characteristics at diagnosis and at surgery and trends over time.
METHODS: The VRPR is a population-based series of all RPs performed in Victoria from July 1995 to December 2000 (n=2,154).
RESULTS: On average, socio-economic status for cases was higher than for the general Victorian population (34% vs 20% in the highest quintile respectively, p<0.0001). The proportion of PSA-detected cases increased from 53% in 1995 to 79% in 2000 (p for linear trend=0.0004). Age at surgery and PSA levels at diagnosis decreased over time (p=0.006 and p=0.04 respectively). The proportion of cases with Gleason score < or =5 from RP decreased from 35% in 1995 to 14% in 2000, while cases with Gleason score 6-7 increased from 60% to 79%. Similar trends were observed for Gleason score from biopsy. We found little evidence of significant trends over time in other pathological characteristics relevant to prognosis. CONCLUSION AND IMPLICATIONS: The VRPR provides a unique whole of population based description of radical prostatectomy in Victoria, confirms findings previously reported in single institution clinical series overseas such as migration to younger age at surgery and to Gleason scores 6 to 7, and provides a resource for evaluating RP outcomes in the future.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20078569     DOI: 10.1111/j.1753-6405.2009.00448.x

Source DB:  PubMed          Journal:  Aust N Z J Public Health        ISSN: 1326-0200            Impact factor:   2.939


  6 in total

1.  Interval to biochemical recurrence following radical prostatectomy does not affect survival in men with low-risk prostate cancer.

Authors:  D M Bolton; A Ta; M Bagnato; D Muller; N L Lawrentschuk; G Severi; R R Syme; G G Giles
Journal:  World J Urol       Date:  2013-07-04       Impact factor: 4.226

2.  Obtaining high quality transcriptome data from formalin-fixed, paraffin-embedded diagnostic prostate tumor specimens.

Authors:  Chol-Hee Jung; Ee Ming Wong; Liesel M FitzGerald; JiHoon E Joo; Jodee A Gould; Vivien Vasic; Julie K Bassett; Neil O'Callaghan; Tim Nottle; John Pedersen; Graham G Giles; Melissa C Southey
Journal:  Lab Invest       Date:  2018-01-16       Impact factor: 5.662

3.  Projecting prevalence by stage of care for prostate cancer and estimating future health service needs: protocol for a modelling study.

Authors:  Xue Q Yu; David P Smith; Mark S Clements; Manish I Patel; Bill McHugh; Dianne L O'Connell
Journal:  BMJ Open       Date:  2011-04-07       Impact factor: 2.692

4.  Increased prostate cancer specific mortality following radical prostatectomy in men presenting with voiding symptoms-A whole of population study.

Authors:  Anthony D Ta; Nathan P Papa; Nathan Lawrentschuk; Jeremy L Millar; Rodney Syme; Graham G Giles; Damien M Bolton
Journal:  Prostate Int       Date:  2015-07-17

5.  Gleason group concordance between biopsy and radical prostatectomy specimens: A cohort study from Prostate Cancer Outcome Registry - Victoria.

Authors:  Sue M Evans; Varuni Patabendi Bandarage; Caroline Kronborg; Arul Earnest; Jeremy Millar; David Clouston
Journal:  Prostate Int       Date:  2016-08-03

6.  Clinician-led improvement in cancer care (CLICC)--testing a multifaceted implementation strategy to increase evidence-based prostate cancer care: phased randomised controlled trial--study protocol.

Authors:  Bernadette Bea Brown; Jane Young; David P Smith; Andrew B Kneebone; Andrew J Brooks; Miranda Xhilaga; Amanda Dominello; Dianne L O'Connell; Mary Haines
Journal:  Implement Sci       Date:  2014-05-29       Impact factor: 7.327

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.